Merck Kommanditgesellschaft Auf Stock Today
| MKGAF Stock | USD 144.31 0.12 0.08% |
PerformanceVery Weak
| Odds Of DistressLow
|
MERCK Kommanditgesells is trading at 144.31 as of the 26th of March 2025. This is a 0.08% down since the beginning of the trading day. The stock's lowest day price was 140.41. MERCK Kommanditgesells has less than a 17 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 26th of December 2024 and ending today, the 26th of March 2025. Click here to learn more.
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kgaa operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. The company has 129.24 M outstanding shares. More on MERCK Kommanditgesellschaft auf
Moving together with MERCK Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
MERCK Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
MERCK Kommanditgesellschaft auf [MKGAF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 85.76 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MERCK Kommanditgesells's market, we take the total number of its shares issued and multiply it by MERCK Kommanditgesells's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MERCK Kommanditgesells classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 129.24 M outstanding shares.
MERCK Kommanditgesellschaft auf has accumulated about 1.71 B in cash with 4.62 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.93.
Check MERCK Kommanditgesells Probability Of Bankruptcy
Ownership AllocationMERCK Kommanditgesells maintains a total of 129.24 Million outstanding shares. Over half of MERCK Kommanditgesells' outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MERCK Ownership Details
MERCK Kommanditgesells Risk Profiles
| Mean Deviation | 2.31 | |||
| Semi Deviation | 2.67 | |||
| Standard Deviation | 2.99 | |||
| Variance | 8.91 |
MERCK Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in MERCK Kommanditgesells without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
MERCK Kommanditgesells Corporate Management
| Matthias Heinzel | CEO Board | Profile | |
| Peter Guenter | CEO Board | Profile | |
| Barbara Weiland | Chief Officer | Profile | |
| Dirk Toepfer | Chief Officer | Profile | |
| Gerhard Schmitz | Head Accounting | Profile | |
| Belen MD | Chair CEO | Profile | |
| Kai Beckmann | Head of Group HR, General Partner and Member of Executive Board | Profile |
Other Information on Investing in MERCK Pink Sheet
MERCK Kommanditgesells financial ratios help investors to determine whether MERCK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MERCK with respect to the benefits of owning MERCK Kommanditgesells security.